167 related articles for article (PubMed ID: 17671804)
1. Deficits in the electroretinogram in neovascular age-related macular degeneration and changes during photodynamic therapy.
Mackay AM; Brown MC; Hagan RP; Fisher AC; Grierson I; Harding SP
Doc Ophthalmol; 2007 Sep; 115(2):69-76. PubMed ID: 17671804
[TBL] [Abstract][Full Text] [Related]
2. A comparison of pattern and multifocal electroretinography in the evaluation of age-related macular degeneration and its treatment with photodynamic therapy.
Neveu MM; Tufail A; Dowler JG; Holder GE
Doc Ophthalmol; 2006 Sep; 113(2):71-81. PubMed ID: 16972084
[TBL] [Abstract][Full Text] [Related]
3. Transient reduction in retinal function revealed by multifocal electroretinogram after photodynamic therapy.
Lai TY; Chan WM; Lam DS
Am J Ophthalmol; 2004 May; 137(5):826-33. PubMed ID: 15126146
[TBL] [Abstract][Full Text] [Related]
4. [Testing central retinal function with multifocal electroretinography before and after photodynamic therapy].
Rüther K; Breidenbach K; Schwartz R; Hassenstein A; Richard G
Ophthalmologe; 2003 Jun; 100(6):459-64. PubMed ID: 12820013
[TBL] [Abstract][Full Text] [Related]
5. Photodynamic effects on retinal oxygen saturation, blood flow, and electrophysiological function in patients with neovascular age-related macular degeneration.
Tsuchihashi T; Mori K; Peyman G; Shimada Y; Yoneya S
Retina; 2009; 29(10):1450-6. PubMed ID: 19816240
[TBL] [Abstract][Full Text] [Related]
6. Different transitions of multifocal electroretinogram recordings between patients with age-related macular degeneration and polypoidal choroidal vasculopathy after photodynamic therapy.
Imai H; Honda S; Nakanishi Y; Yamamoto H; Tsukahara Y; Negi A
Br J Ophthalmol; 2006 Dec; 90(12):1524-30. PubMed ID: 16825279
[TBL] [Abstract][Full Text] [Related]
7. Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization.
Spaide RF; Sorenson J; Maranan L
Ophthalmology; 2003 Aug; 110(8):1517-25. PubMed ID: 12917166
[TBL] [Abstract][Full Text] [Related]
8. Monitoring retinal function in neovascular maculopathy using multifocal electroretinography - early and long-term correlation with clinical findings.
Jurklies B; Weismann M; Hüsing J; Sutter EE; Bornfeld N
Graefes Arch Clin Exp Ophthalmol; 2002 Apr; 240(4):244-64. PubMed ID: 11981638
[TBL] [Abstract][Full Text] [Related]
9. Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study.
Brown DM; Michels M; Kaiser PK; Heier JS; Sy JP; Ianchulev T;
Ophthalmology; 2009 Jan; 116(1):57-65.e5. PubMed ID: 19118696
[TBL] [Abstract][Full Text] [Related]
10. Triamcinolone acetonide as adjunctive treatment to verteporfin in neovascular age-related macular degeneration: a prospective randomized trial.
Chaudhary V; Mao A; Hooper PL; Sheidow TG
Ophthalmology; 2007 Dec; 114(12):2183-9. PubMed ID: 18054638
[TBL] [Abstract][Full Text] [Related]
11. Verteporfin photodynamic therapy combined with intravitreal bevacizumab for neovascular age-related macular degeneration.
Kaiser PK; ; Boyer DS; Garcia R; Hao Y; Hughes MS; Jabbour NM; Kaiser PK; Mieler W; Slakter JS; Samuel M; Tolentino MJ; Roth D; Sheidow T; Strong HA
Ophthalmology; 2009 Apr; 116(4):747-55, 755.e1. PubMed ID: 19243834
[TBL] [Abstract][Full Text] [Related]
12. The changes of pattern electroretinography at the early stage of photodynamic therapy.
Oner A; Karakucuk S; Mirza E; Erkilic K
Doc Ophthalmol; 2005 Sep; 111(2):107-12. PubMed ID: 16514492
[TBL] [Abstract][Full Text] [Related]
13. [Clinical trial of verteporfin photodynamic therapy in Chinese age-related macular degeneration with subfoveal predominant choroidal neovascularization patients].
Chen YX; Ge J; Yan M; Jin CJ; Zhang MX; Dong FT; Lu F; Zhang CF; Zhao JL
Zhonghua Yan Ke Za Zhi; 2007 Mar; 43(3):198-205. PubMed ID: 17605900
[TBL] [Abstract][Full Text] [Related]
14. Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization.
Spaide RF; Sorenson J; Maranan L
Ophthalmology; 2005 Feb; 112(2):301-4. PubMed ID: 15691567
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy with verteporfin for choroidal neovascularization due to age-related macular degeneration and other causes: a New Zealand outcomes study.
Sharp DM; Lai S; Markey CM
Clin Exp Ophthalmol; 2007; 35(1):24-31. PubMed ID: 17300567
[TBL] [Abstract][Full Text] [Related]
16. Verteporfin photodynamic therapy for extrafoveal choroidal neovascularisation secondary to age-related macular degeneration.
Voelker M; Gelisken F; Ziemssen F; Wachtlin J; Grisanti S
Graefes Arch Clin Exp Ophthalmol; 2005 Dec; 243(12):1241-6. PubMed ID: 16010552
[TBL] [Abstract][Full Text] [Related]
17. Verteporfin therapy and intravitreal bevacizumab combined and alone in choroidal neovascularization due to age-related macular degeneration.
Lazic R; Gabric N
Ophthalmology; 2007 Jun; 114(6):1179-85. PubMed ID: 17544776
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal bevacizumab (Avastin) in combination with verteporfin photodynamic therapy for choroidal neovascularization associated with age-related macular degeneration (IBeVe Study).
Costa RA; Jorge R; Calucci D; Melo LA; Cardillo JA; Scott IU
Graefes Arch Clin Exp Ophthalmol; 2007 Sep; 245(9):1273-80. PubMed ID: 17333238
[TBL] [Abstract][Full Text] [Related]
19. Selective photodynamic therapy for neovascular age-related macular degeneration with polypoidal choroidal neovascularization.
Eandi CM; Ober MD; Freund KB; Slakter JS; Yannuzzi LA
Retina; 2007 Sep; 27(7):825-31. PubMed ID: 17891004
[TBL] [Abstract][Full Text] [Related]
20. Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration.
Augustin AJ; Schmidt-Erfurth U
Ophthalmology; 2006 Jan; 113(1):14-22. PubMed ID: 16360209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
